NRGN and Alzheimer disease: Random-effects meta-analysis was performed, and the results showed that CSF Ng levels were significantly elevated in AD patients compared with healthy control subjects (SMD: 0.84 [95% CI: 0.70–0.98], z = 11.72, P < 0.001, Fig. 1 and Supplementary Table S4).